Cardiovascular Therapy and Prevention (Russian Federation) · Published 2026-07-31 · DOI 10.15829/1728-8800-2026-4744
G. A. Konovalov, M. G. Chashchin, Z. I. Khutaeva, M. B. Mukhtarov, Z. M. Musaeva, H. A. Khashieva, V. S. Rabicheva, A. Yu. Gorshkov, O. M. Drapkina
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Konovalov, G., Chashchin, M., Khutaeva, Z., et al. (2026). Efficacy of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with extremely high lipoprotein(a) levels >180 mg/dL. Cardiovascular Therapy and Prevention (Russian Federation). https://doi.org/10.15829/1728-8800-2026-4744